Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Katherine Brown

Physician Assistant Atlanta, GA Physician Assistant

NPI 1427202068 CMS profile 10694317

5887 Glenridge Dr, Suite 140, Atlanta, GA 30328

Open in the dashboard

General payments

$12,056

573 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Katherine Brown of Atlanta, GA is reported in the CMS Open Payments database as having received $12,056 across 573 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19 1
2024 General $1,520 64
2023 General $3,690 172
2022 General $2,920 166
2021 General $3,907 170

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Katherine Brown
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Katherine Brown were reported at $19. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Katherine Brown Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $3,907 $132 $37–$438 $132
2022 $2,920 $155 $48–$522 $149
2023 $3,690 $167 $52–$557 $160
2024 $1,520 $178 $55–$600 $164
2025 $19 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $2,064 143 payments
  2. Supernus Pharmaceuticals, Inc. $1,229 10 payments
  3. Neurelis, Inc. $710 28 payments
  4. Lundbeck LLC $609 29 payments
  5. UCB, Inc. $576 23 payments
  6. SK Life Science, Inc. $509 19 payments
  7. Impel Pharmaceuticals Inc. $472 37 payments
  8. Biohaven Pharmaceuticals, Inc. $457 21 payments
  9. Teva Pharmaceuticals USA, Inc. $410 22 payments
  10. Upsher-Smith Laboratories LLC $407 33 payments
  11. Other $4,613 208 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $11,043 571 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,000 1 payment
  3. Education $12 1 payment
Products named General payments · program years 2021–2025
  1. QULIPTA $1,201 73 payments
  2. OXTELLAR XR $1,040 2 payments
  3. NURTEC ODT Primary Care $823 42 payments
  4. VALTOCO $710 28 payments
  5. UBRELVY $591 58 payments
  6. APTIOM $554 22 payments
  7. Briviact $552 22 payments
  8. TOSYMRA $407 33 payments
  9. ZEMBRACE SYMTOUCH $407 33 payments
  10. NURTEC ODT Pain $388 21 payments
  11. Other $5,847 284 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

573 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record